As too high MYC levels are potentially dangerous for cancer cells, targeting of MYC by miR‐17‐5p may be a means to maintain optimal MYC levels and sustain continuous tumor growth (Liu et al., 2016). The gene discussed is MYC; the disease is neoplasm.